Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saracatinib in Previously Treated Metastatic Pancreatic Cancer
NCT00735917Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2008
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of saracatinib in pancreatic adenocarcinoma (PDAC), sponsored by National Cancer Institute. Started Oct 2008; status: completed.
02
Drugs
saracatinib
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00735917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00735917.